Anorexia nervosa (AN) is a common, severe and disabling psychiatric disorder, characterized by profound weight loss and body image disturbance.
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Anorexia nervosa (AN) is a common, severe and disabling psychiatric disorder, characterized by profound weight loss and body image disturbance.
1 Family and twin studies indicate a significant genetic contribution 2, 3 and pharmacological data suggest possible dysfunction of the serotonergic 4, 5 and dopaminergic [6] [7] [8] [9] pathways. Catechol-O-methyltransferase (COMT) is a candidate gene for mediating susceptibility to AN since it is involved in the dopamine catabolism 10 and because its functional polymorphism (Val/Met 158) determines high (H) and low (L) enzymatic activity alleles.
11 Fifty-one Israeli AN patients and their parents were genotyped with the COMT polymorphism. Using the haplotype relative risk (HRR) method it was found that the frequency of the H allele among alleles transmitted to AN patients from their parents was significantly higher than in those not transmitted (68% vs 51% Fifty-one DSM-IV anorexia nervosa female patients and both their parents were genotyped for the COMT gene (valine to methionine at codon 158) polymorphism. In the light of inherent problems facing association studies, we used the haplotype relative risk (HRR) 12 and the transmission disequilibrium test (TDT) 13 methods that are robust to artifacts caused by population stratification. The genotypes in each family were examined and analyzed so as to determine which of the parents' alleles were transmitted to the affected daughters. The non-transmitted alleles were used to construct the nontransmitted genotypes. According to the HRR method, genotypes and alleles in the patient population are compared with the non-transmitted alleles and genotypes that form the optimal ethnically matched control population. The distribution of the transmitted and non-transmitted genotypes and alleles in the fifty-one trios is presented in Table 1 .
Homozygotes for the high activity allele (HH) were significantly more frequent among AN patients than in the non-transmitted controls (51% vs 29%, 2 = 4.01, df = 1, P = 0.043; odds ratio: 2.50, 95% CI 1.10-5.64). When allelic distribution was compared, it was found that the high activity allele is significantly more common among patients than in the non-transmitted alleles (68% vs 51%, 2 = 5.20, df = 1, P = 0.023, odds ratio: 2.01, 95% CI 1.39-3.55). The parent population did not differ from the 172 healthy Israeli controls in terms of genotypic and allelic distribution. The frequency of COMT alleles is identical in Ashkenazi and non-Ashkenazi Jews.
14 Table 2 shows a TDT analysis of the 51 family trios. Among the forty-nine parents who were heterozygous for the COMT polymorphism (H/L), 33 transmitted the H allele to their offspring and 16 transmitted the L allele (McNemar's 2 = 5.90, df = 1, P = 0.015, odds ratio = 2.06, 95% CI 1.10-3.91). No significant differences in allelic distribution were observed between AN patients with or without comorbid mood disorders.
This report provides evidence for an association of the high activity allele of the COMT gene with anorexia nervosa, suggesting that this gene may contribute to the genetic susceptibility for the disorder. The fact that individuals homozygous for the high activity allele (HH) were found to have a two-fold increased risk of developing AN may indicate a recessive mechanism. It is tempting to attribute this finding to the biological activity of the COMT enzyme in the context of catecholamines and catechol estrogen systems. The high activity allele of COMT has been found to be associated with ADHD 15 and polysubstance abuse, 16 and its impact on behavior is suggested to be mediated by reduction of available dopamine. COMT has also been associated with a dysfunction of the estrogen metabolism, as females who are homozygous for the low activity allele, have an increased risk of breast cancer. 17 Interestingly, a family-based association study of COMT alleles in German AN patients (Klauck et al, 
German
Cancer Research Center, personal communication) has also shown an association of AN with the COMT gene. Surprisingly, susceptibility to AN was associated with the L allele in their population. The fact that AN was significantly associated with the COMT gene but to different alleles, may indicate that the 'true' molecular variant is in linkage disequilibrium with the H allele in one population and with the L allele in the other. This may indicate that the biological activity of the H and L alleles of COMT is not responsible per se for susceptibility to AN, but that these alleles are in linkage disequilibrium with another, adjacent, polymorphism which is the actual genetic susceptibility site associated with the disorder. Several polymorphic sites were found in the coding, non-coding and promoter regions of the COMT and the nearby ARVCF genes. 18 Any of these polymorphisms or a particular haplotype combining them might be candidates for AN susceptibility. In that respect, it is interesting to note that a family-based linkage disequilibrium study of schizophrenia in a Chinese population found a five marker schizophrenia-related haplotype consisting of alleles of the COMT and ARVCF genes. 18 The association of the disorder with this haplotype was much more significant than with the COMT Val/Met alone. We will attempt to identify a specific haplotype associated with AN in our population.
In the present study, an association of COMT with AN has been shown for female patients. It would be interesting to see whether the same holds true for male AN patients since association of COMT alleles with OCD in males 19 and with bipolar disorder in females 20 indicates sexual dimorphism.
Materials and methods

Patients
Patients were recruited from clinics specializing in eating disorders. Parents were approached by the treating physician and were requested to participate in the study. All fifty-one patients were females, age 16.0 ± 2.7 years, body mass index (BMI) 14.80 ± 1.83 kg m −2 . Patients and parents underwent a structured interview (SCID-P or K-SADS lifetime version). Diagnoses of AN and other axis I disorders were established according to DSM-IV criteria. Exclusion criteria included: past or present physical illness and schizophrenic, schizophreniform or delusional disorders. Most of the patients (39/51) were of the restrictive type. Lifetime comorbidity: mood disorder, 20 patients; obsessive compulsive disorder (OCD), eight patients; and other anxiety disorders, five patients. Four patients had an affected AN sister. Mood and/or anxiety disorders were detected in 22% and 17% of mothers and fathers respectively, a frequency within the range that was previously reported. 21 Ethnic background: two thirds of the patients were Ashkenazi Jews and the rest were of non-Ashkenazi or mixed origin. The study was approved by the Institutional Review Board. All participants signed an informed consent form after the nature of the study had been explained to them.
DNA preparation and genotyping
Ten-milliliter venous blood samples were collected from each participant and DNA was extracted by a commercial kit (Boehringer Mannheim, Germany). All participants were genotyped for COMT polymorphism as follows: the high and low-activity alleles in exon 4 (codon 158) were detected by amplification of a 169-bp fragment and subsequent digestion with NIaIII. 22 The presence of the restriction site identified the lowactivity allele (L) and its absence the high-activity allele (H).
Statistics
Analysis of the distribution of the transmitted and nontransmitted alleles was performed by the HRR 12 and TDT 13 methods with the appropriate chi square analyses.
